Filing Details
- Accession Number:
- 0001209191-20-055037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-16 15:41:31
- Reporting Period:
- 2020-10-15
- Accepted Time:
- 2020-10-16 15:41:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1668243 | Urogen Pharma Ltd. | URGN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1585839 | P. Peter Pfreundschuh | 400 Alexander Park Drive Princeton NJ 08540 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2020-10-15 | 4,917 | $0.00 | 12,805 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2020-10-15 | 976 | $21.80 | 11,829 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2020-10-15 | 407 | $21.82 | 11,422 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2020-10-15 | 1,017 | $21.72 | 10,405 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Restricted Stock Units | Disposition | 2020-10-15 | 833 | $0.00 | 833 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Disposition | 2020-10-15 | 2,084 | $0.00 | 2,084 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Disposition | 2020-10-15 | 2,000 | $0.00 | 2,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,667 | No | 4 | M | Direct | ||
| 2,082 | No | 4 | M | Direct | ||
| 4,000 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
- The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 5,000 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. In September the award was modified to accelerate vesting at October 15, 2020 for amounts of RSUs that would have otherwise become vested as of April 15, 2021.
- The reporting person was granted restricted stock units ("RSUs") on August 20, 2018 representing 5,000 ordinary shares. 33.33% of the RSUs vested on August 20, 2019 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. In September the award was modified to accelerate vesting at October 15, 2020 for amounts of RSUs that would have otherwise become vested as of April 15, 2021.
- The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 5,000 ordinary shares. Under the original terms of the agreement, 33.33% of the RSUs will vest on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. In September the award was modified to accelerate vesting at October 15, 2020 for amounts of RSUs that would have otherwise become vested as of April 15, 2021.
Billionaire Hedge Funds
